KZIA
KAZIA THERAPEUTICS LTD
$14.46
▲ +1.69%$14.46▲ +136.66%
over 1Y
L $5.00EODHDH $15.72
Today+1.7%
1W+3.3%
1M+15.1%
3M+97.8%
YTD+189.2%
1Y+136.7%
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 9 analysts
Buy
Mixed signals in the latest filings.
KAZIA THERAPEUTICS LTD shows limited reported revenue.
On these fundamentals, KZIA screens as SELL on the SEC figures.
Financials · annual, by fiscal year
No income data filed.
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$165M
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield—
FCF yield—
Quality & risk
ROIC (est.)—
Free cash flow—
Total debt—
Net cash—
Capital returns
Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+143.2%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Recent filings
all on EDGAR ↗4Period ending 2026-06-192026-06-23open ↗4Period ending 2026-06-192026-06-23open ↗3Period ending 2026-06-012026-06-15open ↗3Period ending 2026-03-182026-06-03open ↗424B3Filing2026-06-02open ↗424B3Filing2026-06-02open ↗424B3Filing2026-06-02open ↗424B3Filing2026-06-02open ↗6-KPeriod ending 2026-06-022026-06-02open ↗SCHEDULE 13G/AFiling2026-05-27open ↗424B3Filing2026-05-26open ↗424B3Filing2026-05-26open ↗
Frequently asked
- Is KAZIA THERAPEUTICS LTD (KZIA) a buy?
- KZIA currently carries a Sell rating with 2/5 conviction, derived from its latest SEC filings. Mixed signals in the latest filings.
- What is KAZIA THERAPEUTICS LTD's quality score?
- KZIA scores 83.46015177278166/100 (grade A) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001075880, latest 10-Q filed 2006-11-07) · EODHD · as of 7/1/2026, 2:16:01 AM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.